Sorafenib Active Not Recruiting Phase 2 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00499525Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer